News
CRISPR Therapeutics’ Strategic Move Amidst Gene Therapy Challenges (NASDAQ:CRSP)
Casgevy's Rollout: A Genetic Leap or Stumble? I last visited CRISPR Therapeutics (NASDAQ:CRSP) in January. Recall that CRISPR's Casgevy is…
Rithm Capital: A Deep-Value Investment With A 9% Yield (NYSE:RITM)
Rithm Capital (NYSE:RITM) is growing its business, seeing solid earnings available for distribution strength and supplying a well-supported dividend for…
Embracer: Split Sensitivity Analysis, RemainCo Is Gutted (OTCMKTS:THQQF)
Embracer (OTCPK:THQQF)(OTCPK:EBCRY) has been making moves. In addition to the relatively uneconomical Saber Interactive and Gearbox Entertainment disposals, the latter…
Burlington Stores Q1: Stay Buy Rated As Stock Continues To Deliver (NYSE:BURL)
Investment action I recommended a buy rating for Burlington Stores (NYSE:BURL) when I wrote about it in late March this…
My Top 10 High Yield Dividend Stocks For June 2024
Market Recap The brief market pullback in April was quickly forgotten in May, the SPDR S&P 500 ETF Trust (SPY)…
Palo Alto: Deferred Billings Impact FCF Amid Growth Slowdown (NASDAQ:PANW)
Investment Thesis Palo Alto Networks, Inc. (NASDAQ:PANW)'s stock has tanked almost a 30% after the 3Q FY2024 earnings results. I…
Citigroup: Next Level Up (NYSE:C)
Citigroup (NYSE:C) has long been one of the most undervalued bank stocks, but the company has struggled to generate the…
The Stock Market Was Up In May; Still Expecting More “Up”
The United States stock markets performed well in May, even though they went through a down period that looked a…